Importance of lack of interest in patients with mild cognitive impairment

Philippe H Robert1, Claudine Berr, Magali Volteau

  • 1Centre Mémoire de Ressources et de Recherche, CHU de Nice, INSERM JE 2441, Nice, France. phil.robert15@orange.fr

Abstract

Insights

Lack of interest, a key apathy dimension, significantly increases Alzheimer disease risk in mild cognitive impairment patients. Early detection of this behavioral sign is crucial for monitoring cognitive decline.

Area of Science:

  • Neurology
  • Gerontology
  • Psychiatry

Background:

  • Apathy is a prevalent behavioral symptom in mild cognitive impairment (MCI).
  • Understanding apathy's dimensions is crucial for predicting neurodegenerative disease progression.

Purpose of the Study:

  • To investigate how apathy dimensions (emotional blunting, lack of initiative, lack of interest) influence Alzheimer disease (AD) risk in MCI patients.
  • To identify specific apathy markers associated with MCI to AD conversion.

Main Methods:

  • Longitudinal study conducted across fourteen French memory clinics.
  • 214 MCI patients were assessed for apathy using the Apathy Inventory.
  • Neuropsychiatric evaluation included anxiety and depression scales over a 3-year follow-up period.

Main Results:

  • 59 patients (27.2%) progressed to AD within 3 years.
  • A significant increase in Alzheimer disease (AD) conversion risk was observed in patients exhibiting a lack of interest.
  • Cox regression analyses confirmed lack of interest as a significant predictor, independent of age, gender, and education.

Conclusions:

  • Lack of interest, a subtle behavioral symptom, may serve as an early indicator of cognitive decline in MCI.
  • Regular cognitive status checks are recommended for MCI patients displaying apathy, particularly a lack of interest.

Related Concept Videos

Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...